Aurigene Oncology gets DCGI nod for phase-2 trials of CAR-T cell therapy Ribrecabtagene autoleucel – Times of India
Aurigene Oncology lab (Picture credit: Aurigene Oncology Limited) HYDERABAD: Dr Reddy’s Laboratories’ wholly-owned subsidiary, Aurigene Oncology Limited, has received Drugs Controller General of India (DCGI) approval for conducting a phase-2…